HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.

Abstract
Neurofibromatosis type 1 (NF1), the most common genetic disorder affecting the human nervous system, is characterized by the development of multiple benign Schwann cell tumors in skin and large peripheral nerves. These neoplasms, which are termed dermal and plexiform neurofibromas respectively, have distinct clinical courses; of particular note, plexiform, but not dermal, neurofibromas often undergo malignant progression to form malignant peripheral nerve sheath tumors (MPNSTs), the most common malignancy occurring in NF1 patients. In recent years, a number of genetically engineered mouse models have been created to investigate the molecular mechanisms driving the pathogenesis of these tumors. These models have been designed to address key questions including: (1) whether NF1 loss in the Schwann cell lineage is essential for tumorigenesis; (2) what cell type(s) in the Schwann cell lineage gives rise to dermal neurofibromas, plexiform neurofibromas and MPNSTs; (3) how the tumor microenvironment contributes to neoplasia; (4) what additional mutations contribute to neurofibroma-MPNST progression; (5) what role different neurofibromin-regulated Ras proteins play in this process and (6) how dysregulated growth factor signaling facilitates PNS tumorigenesis. In this review, we summarize the major findings from each of these models and their limitations as well as how discrepancies between these models may be reconciled. We also discuss how information gleaned from these models can be synthesized to into a comprehensive model of tumor formation in peripheral nervous system and consider several of the major questions that remain unanswered about this process.
AuthorsNicole M Brossier, Steven L Carroll
JournalBrain research bulletin (Brain Res Bull) Vol. 88 Issue 1 Pg. 58-71 (May 01 2012) ISSN: 1873-2747 [Electronic] United States
PMID21855613 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Review)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Topics
  • Animals
  • Cell Transformation, Neoplastic (genetics, metabolism, pathology)
  • Disease Models, Animal
  • Genes, Neurofibromatosis 1
  • Genetic Engineering
  • Humans
  • Mice
  • Mice, Neurologic Mutants
  • Nerve Sheath Neoplasms (genetics, metabolism, pathology)
  • Neurofibroma, Plexiform (genetics, metabolism, pathology)
  • Neurofibromatoses (genetics, metabolism, pathology)
  • Neurofibromatosis 1 (genetics, metabolism, pathology)
  • Peripheral Nervous System Neoplasms (genetics, metabolism, pathology)
  • Tumor Microenvironment (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: